LLY vs MRK Analysis
Both LLY and MRK operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.
LLY has a 3.1x larger market capitalization than MRK.
MRK trades at a lower P/E ratio (15.9x) compared to LLY (42.9x), suggesting MRK may be more attractively valued relative to its earnings.
MRK offers a higher dividend yield (2.93%) vs LLY (0.63%), making it more attractive for income investors.
Looking at profitability, LLY has a profit margin of 3166.4% while MRK's is 2811.5%. LLY converts more of its revenue into profit.
In terms of growth, LLY has revenue growth of 42.6% versus 5.0% for MRK. LLY is growing its top line faster.